These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22150307)

  • 1. TAM receptors in leukemia: expression, signaling, and therapeutic implications.
    Brandão L; Migdall-Wilson J; Eisenman K; Graham DK
    Crit Rev Oncog; 2011; 16(1-2):47-63. PubMed ID: 22150307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the TAM Receptors in Leukemia.
    Huey MG; Minson KA; Earp HS; DeRyckere D; Graham DK
    Cancers (Basel); 2016 Nov; 8(11):. PubMed ID: 27834816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Inflammatory Role of TAM Family of Receptor Tyrosine Kinases Via Modulating Macrophage Function.
    Lee CH; Chun T
    Mol Cells; 2019 Jan; 42(1):1-7. PubMed ID: 30699285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated expression of tyro3, axl, and mer receptors in macrophage ontogeny.
    Malawista A; Wang X; Trentalange M; Allore HG; Montgomery RR
    Macrophage (Houst); 2016; 3():. PubMed ID: 27695708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of TAM receptor tyrosine kinases in the mammalian testis and immunoprivileged sites.
    Deng T; Chen Q; Han D
    Front Biosci (Landmark Ed); 2016 Jan; 21(2):316-27. PubMed ID: 26709775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).
    Krause S; Pfeiffer C; Strube S; Alsadeq A; Fedders H; Vokuhl C; Loges S; Waizenegger J; Ben-Batalla I; Cario G; Möricke A; Stanulla M; Schrappe M; Schewe DM
    Blood; 2015 Jan; 125(5):820-30. PubMed ID: 25428221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and localization of receptor tyrosine kinase Tyro3 in rat brain.
    Zhao QM; Li LM; Zhang C; Guo R
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 44(6):905-10. PubMed ID: 23247456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promiscuity and selectivity of small-molecule inhibitors across TAM receptor tyrosine kinases in pediatric leukemia.
    Liu MH; Chen SB; Yu J; Liu CJ; Zhang XJ
    J Mol Graph Model; 2017 Aug; 75():125-131. PubMed ID: 28551502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.
    Pierce AM; Keating AK
    Brain Res; 2014 Jan; 1542():206-20. PubMed ID: 24184575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAM receptor signaling in immune homeostasis.
    Rothlin CV; Carrera-Silva EA; Bosurgi L; Ghosh S
    Annu Rev Immunol; 2015; 33():355-91. PubMed ID: 25594431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAM kinases as regulators of cell death.
    Post SM; Andreeff M; DiNardo C; Khoury JD; Ruvolo PP
    Biochim Biophys Acta Mol Cell Res; 2021 May; 1868(6):118992. PubMed ID: 33647320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons.
    Prieto AL; O'Dell S; Varnum B; Lai C
    Neuroscience; 2007 Dec; 150(2):319-34. PubMed ID: 17980494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAM receptor signalling and demyelination.
    Binder MD; Kilpatrick TJ
    Neurosignals; 2009; 17(4):277-87. PubMed ID: 19816064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression.
    Duan Y; Wong W; Chua SC; Wee HL; Lim SG; Chua BT; Ho HK
    Int J Oncol; 2016 Jan; 48(1):358-66. PubMed ID: 26573872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview.
    Wium M; Paccez JD; Zerbini LF
    Cells; 2018 Oct; 7(10):. PubMed ID: 30322068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophages.
    Zheng S; Hedl M; Abraham C
    J Immunol; 2015 Feb; 194(4):1928-37. PubMed ID: 25567680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
    Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
    Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment.
    Wang KH; Ding DC
    Tzu Chi Med J; 2021; 33(3):250-256. PubMed ID: 34386362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Tyro3 receptor tyrosine kinase leads to the acquisition of taxol resistance in ovarian cancer cells.
    Lee C
    Mol Med Rep; 2015 Jul; 12(1):1485-92. PubMed ID: 25815442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAM receptors, Phosphatidylserine, inflammation, and Cancer.
    Burstyn-Cohen T; Maimon A
    Cell Commun Signal; 2019 Nov; 17(1):156. PubMed ID: 31775787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.